EXPERIMENTAL MODEL OF SARS COV-2 IN YOUNG SYRIAN HAMSTERS FOR PRECLINICAL STUDIES

Gleb Fomin, Kairat Tabynov, Nurkeldy Turebekov, Dinara Turegeldiyeva, Rinat Islamov

2022

Closed access Metadata (CSL-JSON)
DOI 10.5593/sgem2022/6.1/s25.10
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

SARS-CoV-2 researchers faced the problem of specificity for ACE-2 receptors. In mice and rats, ACE-2 has a low affinity for this virus. In contrast, the Syrian hamster (Mesocricetus auratus) when infected with SARS-CoV-2 show clinical signs of infection with this virus. Therefore, it is necessary to assess the severity of pathological lesions and immune response for relevance to preclinical new drugs against SARS-CoV-2. In this study, we studied blood counts, serum levels of Il-6, TNF-?, IFN-? and IFN-? and the histological state of the lungs of Syrian hamsters. In our study Syrian hamsters showed clinical signs of COVID-19. In infected animals, a decrease in the level of leukocytes and granulocytes was noted. There was some suppression of the immune response, without an increase in the main biomarkers of ARDS. The exception was high levels of TNF-?. Histological examination showed an early exudative phase of moderate ARDS. There were no significant gender differences in the production of pro-inflammatory cytokines. In this study, it was shown that infection with COVID-19 in young Syrian hamsters is modeled with moderate severity, and can be applied in preclinical studies.